MoneyWorks4Me

Sigachi Industries - Quaterly Results

14 Nov 2023 Evaluate
A minor change in the total revenue was seen in the September 2023 quarter. The total revenue for the quarter stood at Rs. 791.72 millions against Rs. 772.22 millions during year ago period.The Company's Net profit for the September 2023 quarter have declined marginally to Rs. 83.78  millions as against Rs. 119.18 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 143.91 millions from 165.11 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 791.72 772.22 2.53 1570.11 1489.19 5.43 2903.24 2494.05 16.41
Other Income 10.93 22.08 -50.50 27.24 38.33 -28.93 66.72 26.30 153.69
PBIDT 143.91 165.11 -12.84 312.33 322.08 -3.03 624.85 530.25 17.84
Interest 16.49 11.98 37.65 29.22 16.72 74.76 42.87 11.55 271.17
PBDT 127.42 153.13 -16.79 283.11 305.36 -7.29 581.98 518.70 12.20
Depreciation 19.81 20.68 -4.21 39.24 28.70 36.72 66.21 29.05 127.92
PBT 107.61 132.45 -18.75 243.87 276.66 -11.85 515.77 489.65 5.33
TAX 23.83 13.27 79.58 58.73 48.61 20.82 100.18 109.37 -8.40
Deferred Tax 8.49 -12.53 -167.76 12.06 -8.92 -235.20 -2.06 10.53 -119.56
PAT 83.78 119.18 -29.70 185.14 228.05 -18.82 415.59 380.28 9.29
Equity 307.43 307.43 0.00 307.43 307.43 0.00 307.43 307.43 0.00
PBIDTM(%) 18.18 21.38 -14.99 19.89 21.63 -8.03 21.52 21.26 1.23
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..